[HTML] springer.comFull View

[HTML][HTML] Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response

M Piepke, BH Clausen, P Ludewig… - Journal of …, 2021 - Springer
Background Lymphocytes have dichotomous functions in ischemic stroke. Regulatory T cells
are protective, while IL-17A from innate lymphocytes promotes the infarct growth. With recent …
被引用次数：36 相关文章

Interleukin-10 Improves Stroke Outcome by Controlling the Detrimental Interleukin-17A Response

M Piepke, BH Clausen, P Ludewig, JH Vienhues… - 2021 - researchsquare.com
Background: Lymphocytes have dichotomous functions in ischemic stroke. Regulatory T
cells are protective, while IL-17A from innate lymphocytes promotes the infarcts growth. With …
[HTML] nih.gov

[HTML][HTML] Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response

M Piepke, BH Clausen, P Ludewig… - Journal of …, 2021 - ncbi.nlm.nih.gov
Background Lymphocytes have dichotomous functions in ischemic stroke. Regulatory T cells
are protective, while IL-17A from innate lymphocytes promotes the infarct growth. With recent …
[HTML] biomedcentral.com

[HTML][HTML] Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response

M Piepke, BH Clausen… - Journal of …, 2021 - jneuroinflammation.biomedcentral …
Lymphocytes have dichotomous functions in ischemic stroke. Regulatory T cells are
protective, while IL-17A from innate lymphocytes promotes the infarct growth. With recent …

Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response

M Piepke, BH Clausen, P Ludewig… - Journal of …, 2021 - search.proquest.com
Background Lymphocytes have dichotomous functions in ischemic stroke. Regulatory T cells
are protective, while IL-17A from innate lymphocytes promotes the infarct growth. With recent …

Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response

M Piepke, BH Clausen, P Ludewig… - Journal of …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Lymphocytes have dichotomous functions in ischemic stroke. Regulatory T cells are …

Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response.

M Piepke, BH Clausen, P Ludewig… - Journal of …, 2021 - go.gale.com
Background Lymphocytes have dichotomous functions in ischemic stroke. Regulatory T cells
are protective, while IL-17A from innate lymphocytes promotes the infarct growth. With recent …

Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response

M Piepke, BH Clausen, P Ludewig… - Journal of …, 2021 - portal.findresearcher.sdu.dk
Background: Lymphocytes have dichotomous functions in ischemic stroke. Regulatory T
cells are protective, while IL-17A from innate lymphocytes promotes the infarct growth. With …

Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response.

M Piepke, BH Clausen, P Ludewig… - Journal of …, 2021 - europepmc.org
Background Lymphocytes have dichotomous functions in ischemic stroke. Regulatory T cells
are protective, while IL-17A from innate lymphocytes promotes the infarct growth. With recent …

Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response

M Piepke, BH Clausen, P Ludewig… - Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Lymphocytes have dichotomous functions in ischemic stroke. Regulatory T cells
are protective, while IL-17A from innate lymphocytes promotes the infarct growth. With recent …